肿瘤新药专题
肿瘤治疗专题
鼻咽癌患者经过中医治疗后病情…
胰腺癌患者中药治疗5个月病情好…
肺癌患者四个月肿瘤缩小3厘米
肝癌患者来我院就诊现病情稳定…
肺癌患者用药三个月肿块缩小
转移扩散浸润性膀胱癌患者经治…
肝癌患者中药治疗10个月病情稳
非霍奇金淋巴瘤患者病情稳定CT…
  肺癌 肝癌
  胃癌 肠癌
  鼻咽癌 食道癌
  乳腺癌 宫颈癌
  胰腺癌 脑瘤
  白血病 恶性淋巴瘤
  胆囊癌 前列腺癌
 
癌症疼痛这个症状怎么治疗好
造成癌性发热的原因主要有哪些
癌症患者总是反复发热的原因
什么是内源性致癌因素
生物致癌因素主要包括哪些
癌症的物理化致癌因素包括哪些
人体癌细胞是怎样产生的呢
癌症的三大认识误区
肿瘤标志物的临床意义具体是怎…
哪些慢性疾病容易发生癌变
首页 >抗癌成果
益肺清化颗粒相关英文报道
[ 2007/4/20 ]

Shanghai.  August 2. INTERFAX-CHINA - Beijing Huashen Pharmaceutical Ltd., a subsidiary of the China Academy of Chinese Medicine Sciences, has launched a medicine to treat lung cancer.

The medicine, Yi Fei Qing Hua granule, was developed by a chief researcher in the academy, who started to cancer study treatment in 1970s.

The unnamed researcher received government awards for his study on the treatment of late stage primary lung cancer patients with Yi Fei Qing Hua capsules.

"The granule is a compound medicine, and has adequate efficacy and low cost," Zhu Xichun, a manager at Beijing Huashen told Interfax. "The medicine is more effective than chemotherapy in controlling cancer by increasing immunization function, and extending life expectancy."

The medicine was made from Radix Astragali, Codonopsis pilosula, almond, and Platycodon grandiflorum, was prepared in the form of oral solution, branded Fei Liu Ping Gao, and used in Guang'anmen Hospital of China Academy of Medical Sciences.

A contrast clinical study of the medicine was made in the 1990s, and involved 195 cases of primary lung cancer patients at a late stage, treated with Fei Liu Ping Gao, and 144 cases, with chemotherapy. 

The result showed that coughs, phlegm, chest pain, shortness of breath and fatigue of the patients in the treatment group improved markedly compared with the chemotherapy group.

By short term efficacy, the X-ray showed that of the 195 cases treated with Fei Liu Ping Gao, 2 were improved, 166 remained stable, and 27 deteriorated. In the 144 cases of the chemotherapy group, 10 were improved, 70 remained stable and 64 deteriorated.

The observation of long term efficacy on the patients showed that of the 28 patients treated with Fei Liu Ping Gao, 6 survived for one year after the treatment, 15 for two years, 4 within three years, and 3 survived for more than three years.

In the 14 cases of the chemotherapy group, 14 survived for one year, and the rest survived for two years. The average survival periods for patients in the treatment group were 12.5 months, and the chemotherapy group, 7.5 months.

Beijing Huashen Pharmaceutical Ltd. introduced TCM production facilities and used an advanced spray-drying granule production method, to prepare Fei Liu Ping Gao oral solution into the Yi Fei Qing Hua granule. The spry-drying method can retain the properties of natural medicines, and enable drugs to be taken at low dosage.          

It can also strengthen the efficacy of chemotherapy when used concurrently with other drugs, and has low gastrointestinal and liver toxicity effects.

"Patients need to pay RMB 1000 (USD 125) per month for the treatment, which is cheap compared with other chemotherapy," Zhu said.

Beijing Huashen Pharmaceutical Ltd. is a joint venture of the China Academy of Medical Sciences and Hong Kong-listed China Resources Holdings Ltd.

 
声明:转载或引用文章仅供参考,不构成任何建议、推荐,不能凭此购药、诊断疾病或开处方。肿瘤属疑难病,请在专家指导下用药治疗
提醒:请以药品使用说明书为准,或谨遵医嘱,如涉及版权问题,请及时与我们联系。
手机版  |  关于我们  |  便民服务  |  乘车路线  |  联系方式  |  友情链接  |   免费电话  |  我们位置
肿瘤病情咨询QQ:1452846328  在线qq交谈
版权所有:中医抗癌网    备案号:京ICP备07032015号